Hypertension Clinical Trials in San Antonio

Showing 181-200 of 208 trials

Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT01279083

To investigate the safety and efficacy of DE-112 in lowering intraocular pressure in subjects with primary open-angle glaucoma or ocular hypertension.

Open-angle GlaucomaOcular Hypertension

Santen Inc.147 participantsStarted Jan 2011

Austin, Texas, United States • San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension

NCT00818883

The purpose of this study is to compare the antihypertensive effect of chlorthalidone vs hydrochlorothiazide when each is used with azilsartan medoxomil, once daily (QD), in participants with moderate to severe essential hypertension.

Essential Hypertension

Takeda609 participantsStarted Feb 2009

Birmingham, Alabama, United States • Gulf Shores, Alabama, United States • Scottsboro, Alabama, United States +50 more locations

Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension

Hypertension Trials in Other Cities

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension

A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)

Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401

Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension

Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age

FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension

Other Conditions in San Antonio